Invention Grant
- Patent Title: Primary carboxamides as BTK inhibitors
- Patent Title (中): 主要羧酰胺作为BTK抑制剂
-
Application No.: US14315504Application Date: 2014-06-26
-
Publication No.: US09567339B2Publication Date: 2017-02-14
- Inventor: Dominique Bonafoux , Heather M. Davis , Kristine E. Frank , Michael M. Friedman , J. Martin Herold , Michael Z. Hoemann , Raymond Huntley , Augustine Osuma , George Sheppard , Gagandeep K. Somal , Jennifer Van Camp , Stacy A. Van Epps , Anil Vasudevan , Grier A. Wallace , Lu Wang , Lu Wang , Zhi Wang , Noel S. Wilson , Xiangdong Xu
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: McCarter & English, LLP
- Agent Elizabeth A. Hanley; Yu Lu
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D417/12 ; C07D471/04 ; C07D209/08 ; C07D417/14 ; C07D401/14 ; C07D403/14 ; C07D231/56 ; C07D401/12
Abstract:
The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Public/Granted literature
- US20150005279A1 PRIMARY CARBOXAMIDES AS BTK INHIBITORS Public/Granted day:2015-01-01
Information query
